Business Description
Grape King Bio Ltd
ISIN : TW0001707008
Description
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in the production and sales of pharmaceutical preparation, patent medicine, liquid tonic, drink, and healthy food. The company has three segments: MLM (Multi-Level Marketing) is a direct seller of Pro-partner Inc, including the Company's development and manufacturing products for Pro-partner Inc, Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others and it derives a majority of its revenue from Taiwan.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 25.76 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 984.69 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 5.36 | |||||
| Beneish M-Score | -2.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.1 | |||||
| 3-Year EBITDA Growth Rate | 0.7 | |||||
| 3-Year EPS without NRI Growth Rate | 1.6 | |||||
| 3-Year FCF Growth Rate | 5.6 | |||||
| 3-Year Book Growth Rate | 11.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.57 | |||||
| 9-Day RSI | 45.56 | |||||
| 14-Day RSI | 47.01 | |||||
| 6-1 Month Momentum % | 6.27 | |||||
| 12-1 Month Momentum % | -10.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.66 | |||||
| Quick Ratio | 1.47 | |||||
| Cash Ratio | 1.36 | |||||
| Days Inventory | 125.44 | |||||
| Days Sales Outstanding | 10.58 | |||||
| Days Payable | 55.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.42 | |||||
| Dividend Payout Ratio | 0.71 | |||||
| 3-Year Dividend Growth Rate | 2 | |||||
| Forward Dividend Yield % | 4.42 | |||||
| 5-Year Yield-on-Cost % | 4.35 | |||||
| 3-Year Average Share Buyback Ratio | -2.8 | |||||
| Shareholder Yield % | 4.4 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.26 | |||||
| Operating Margin % | 23.5 | |||||
| Net Margin % | 13.66 | |||||
| FCF Margin % | 18.03 | |||||
| ROE % | 15.11 | |||||
| ROA % | 9.67 | |||||
| ROIC % | 21.14 | |||||
| ROC (Joel Greenblatt) % | 35.06 | |||||
| ROCE % | 23.47 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.99 | |||||
| PE Ratio without NRI | 15.99 | |||||
| Shiller PE Ratio | 14.34 | |||||
| Price-to-Owner-Earnings | 19.2 | |||||
| PEG Ratio | 17.77 | |||||
| PS Ratio | 2.18 | |||||
| PB Ratio | 2.31 | |||||
| Price-to-Tangible-Book | 2.35 | |||||
| Price-to-Free-Cash-Flow | 12.14 | |||||
| Price-to-Operating-Cash-Flow | 9.24 | |||||
| EV-to-EBIT | 6.89 | |||||
| EV-to-Forward-EBIT | 7.45 | |||||
| EV-to-EBITDA | 5.87 | |||||
| EV-to-Forward-EBITDA | 6.68 | |||||
| EV-to-Revenue | 1.72 | |||||
| EV-to-Forward-Revenue | 1.89 | |||||
| EV-to-FCF | 9.48 | |||||
| Price-to-Projected-FCF | 0.89 | |||||
| Price-to-Median-PS-Value | 0.78 | |||||
| Price-to-Graham-Number | 1.29 | |||||
| Price-to-Net-Current-Asset-Value | 45.75 | |||||
| Earnings Yield (Greenblatt) % | 14.53 | |||||
| FCF Yield % | 8.3 | |||||
| Forward Rate of Return (Yacktman) % | 9.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Grape King Bio Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 10,635.464 | ||
| EPS (TTM) (NT$) | 9.76 | ||
| Beta | 0.49 | ||
| Volatility % | 20.45 | ||
| 14-Day RSI | 47.01 | ||
| 14-Day ATR (NT$) | 2.482892 | ||
| 20-Day SMA (NT$) | 158.45 | ||
| 12-1 Month Momentum % | -10.06 | ||
| 52-Week Range (NT$) | 147.5 - 189 | ||
| Shares Outstanding (Mil) | 148.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Grape King Bio Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Grape King Bio Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Grape King Bio Ltd Frequently Asked Questions
What is Grape King Bio Ltd(TPE:1707)'s stock price today?
The current price of TPE:1707 is NT$156.00. The 52 week high of TPE:1707 is NT$189.00 and 52 week low is NT$147.50.
When is next earnings date of Grape King Bio Ltd(TPE:1707)?
The next earnings date of Grape King Bio Ltd(TPE:1707) is .
Does Grape King Bio Ltd(TPE:1707) pay dividends? If so, how much?
The Dividend Yield %  of Grape King Bio Ltd(TPE:1707) is 4.42% (As of Today), Highest Dividend Payout Ratio of Grape King Bio Ltd(TPE:1707) was 0.73. The lowest was 0.59. And the median was 0.69. The  Forward Dividend Yield % of Grape King Bio Ltd(TPE:1707) is 4.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers